Brief: China Resources Pharmaceutical Says Unit Recently Signed Strategic Deal
20/04/2023 16:55
April 20 (Reuters) - China Resources Pharmaceutical
Group Ltd 3320.HK :
* UNIT RECENTLY SIGNED STRATEGIC DEAL WITH SHENZHEN GAOTEJIA
INVESTMENT, GUANGDONG DANXIA BIO-PHARMACEUTICAL
* DEAL TO ENABLE CR BOYA BIO- PHARMACEUTICAL AND GROUP TO
ENHANCE
THEIR OVERALL COMPETITIVENESS
Source text for Eikon: ID:nHKS6XmtVV
Further company coverage: 3320.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Resources Pharmaceutical
See all newsBrief: China Resources Pharmaceutical Group Declares Interim Dividend Of RMB0.087 Per Share
Brief: China Resources Pharmaceutical Says Tasly Pharmaceutical Posts HY Net Profit Attributable Of RMB 892.7 MLN
Brief: China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion For CR Jiangzhong
Brief: China Resources Pharmaceutical Group Posts HY Revenue RMB 1.64 Billion, Down 50.97% For KPC Pharmaceuticals
Brief: China Resources Pharmaceutical Says CR Boya Bio-Pharmaceutical Posts Quarterly Unaudited Revenue RMB 321.1 Million, Net Profit RMB 30.0 Million